BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29487008)

  • 1. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.
    Saito K; Okuyama T; Miyazaki S; Oi H; Mitsui T; Noro T; Takeshita E; Ono Y; Urahashi T; Tajima H; Yoshitomi H
    In Vivo; 2022; 36(4):1820-1828. PubMed ID: 35738585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
    Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
    Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
    Archilla I; Díaz-Mercedes S; Aguirre JJ; Tarragona J; Machado I; Rodrigo MT; Lopez-Prades S; Gorostiaga I; Landolfi S; Alén BO; Balaguer F; Castells A; Camps J; Cuatrecasas M
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00303. PubMed ID: 33939382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Tanaka M; Miyake O; Masaki T; Shimada Y; Kinugasa Y; Mori Y; Kishimoto M; Kameoka S; Sato Y; Matsuda K; Nakadoi K; Shinto E; Nakamura T; Sugihara K
    Am J Surg Pathol; 2014 Feb; 38(2):197-204. PubMed ID: 24418853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
    J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma.
    Yonemura K; Kajiwara Y; Ao T; Mochizuki S; Shinto E; Okamoto K; Hase K; Ueno H
    Am J Surg Pathol; 2019 Oct; 43(10):1341-1348. PubMed ID: 31318710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of poorly differentiated clusters in the primary tumor in patients undergoing hepatectomy for colorectal liver metastasis.
    Ueno H; Konishi T; Ishikawa Y; Shimazaki H; Ueno M; Aosasa S; Saiura A; Hase K; Yamamoto J
    Surgery; 2015 May; 157(5):899-908. PubMed ID: 25731780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
    Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    Fonseca GM; de Mello ES; Faraj SF; Kruger JAP; Coelho FF; Jeismann VB; Lupinacci RM; Cecconello I; Alves VAF; Pawlik TM; Herman P
    J Surg Oncol; 2018 Jun; 117(7):1364-1375. PubMed ID: 29448312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer.
    Shivji S; Cyr DP; Pun C; Duan K; Sari A; Tomin R; Ng D; Brar A; Zerhouni S; Kennedy E; Brar M; Swallow CJ; Conner J; Kirsch R
    Am J Surg Pathol; 2022 Oct; 46(10):1340-1351. PubMed ID: 35613045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.